Effect of Corton on olfactory dysfunction in COVID-19 patients

Phase 1

Recruiting

• Conditions: Anosmia.; Anosmia; R43.0

• Registration Number: IRCT20200522047542N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients with COVID-19 who have been referred or admitted to Qaem, Imam Reza, or Shariati Hospital diagnosed with a protocol defined by the World Health Organization.
People who have not experienced any signs of reduced sense of smell and taste for at least 2 weeks before the onset of the first manifestation of Covid-19.
People who were diagnosed with hyposmia or anosmia.

Exclusion Criteria

People with certain underlying conditions (such as Parkinson's, Alzheimer's, severe nutritional disorders, acute rhinitis, acute catarrhal sinusitis, SICA syndrome (especially after radiation), nasal mucosal congestion, for example after rhinoplasty, olfactory nerve damage in trauma, etc., which are exposed to the reduction of the sense of smell independent of the coronavirus, as well as, people who experience other viral and bacterial infections simultaneously with COVID-19
People with a history of asthma and allergies are excluded
Participants who refused to participate in follow-up measurements, provide data, or give consent considered withdrawn.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Smell Sense. Timepoint: Time intervals: one week, two weeks, and one month after the intervention. Method of measurement: By VAS test.